Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

578
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
578
C–C Bond Formation: Aldol Condensation Overview01:10

C–C Bond Formation: Aldol Condensation Overview

16.1K
Aldol condensation is an important route in synthetic organic chemistry used to generate a new carbon–carbon bond under basic or acidic conditions. The aldol condensation reaction presented in Figure 1 constitutes an aldol addition reaction followed by the dehydration process.
16.1K
Preparation of Amines: Reductive Amination of Aldehydes and Ketones01:38

Preparation of Amines: Reductive Amination of Aldehydes and Ketones

3.7K
Carbonyl compounds and primary amines undergo reductive amination first to produce imines, followed by secondary amines in the same reaction mixture, using selective reducing agents like sodium cyanoborohydride or sodium triacetoxyborohydride. Reductive amination produces different degrees of substitution of amines depending on the starting amine substrate.
3.7K
Alcohols from Carbonyl Compounds: Reduction02:23

Alcohols from Carbonyl Compounds: Reduction

12.1K
Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
12.1K
Protecting Groups for Aldehydes and Ketones: Introduction01:23

Protecting Groups for Aldehydes and Ketones: Introduction

8.8K
Protecting groups are compounds that can bind to a specific functional group in the presence of other functional groups to protect them from undesired chemical reactions. These compounds can selectively bind to particular functional groups and advance chemoselective reactions in polyfunctional systems (Figure 1). After the functional group has served its purpose, it is removed by reacting it with specific compounds.
8.8K
Preparation of Amines: Reduction of Oximes and Nitro Compounds01:29

Preparation of Amines: Reduction of Oximes and Nitro Compounds

4.6K
Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulatory Roles of Probiotics: From Intestinal Barrier Regulation to Clinical Applications.

Current pharmaceutical biotechnology·2026
Same author

Glycosylation in Cancer Medicines Delivery and Their Patents.

Current drug delivery·2026
Same author

Recent Alzheimer's Research Targets Amyloid-β with Novel Phytochemicals and Pharmacological Strategies for Therapy.

Current aging science·2026
Same author

Empowering molecular complexity <i>via</i> biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products.

RSC medicinal chemistry·2026
Same author

Comprehensive Review of Phytotherapeutic Methods for Treating tuberculosis.

Current drug discovery technologies·2025
Same author

A Comprehensive Review on Immunoregulatory Effects of Phytochemicals.

Current drug discovery technologies·2024

Related Experiment Video

Updated: Jan 18, 2026

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
09:59

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity

Published on: March 31, 2023

1.4K

Development and Exploration of Organic Compounds as Aldose Reductase Inhibitors: An Overview.

Bhanupriya Bhrigu1, Shikha Sharma1, Bimal Krishna Banik2

  • 1Department of Pharmaceutical Science, Lords University, Alwar-301028, Rajasthan, India.

Current Topics in Medicinal Chemistry
|September 8, 2025
PubMed
Summary

Aldose reductase inhibitors (ARIs) show promise for treating diabetic complications by targeting the polyol pathway. This review details ARI chemical classes and research advancements for managing diabetes-related issues.

Keywords:
Aldose reductase inhibitorsdiabetesnephropathy.polyol pathwayretinopathy

More Related Videos

Enzymatic Cascade Reactions for the Synthesis of Chiral Amino Alcohols from L-lysine
09:14

Enzymatic Cascade Reactions for the Synthesis of Chiral Amino Alcohols from L-lysine

Published on: February 16, 2018

12.6K
A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones
07:30

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

Published on: January 21, 2020

8.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
09:59

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity

Published on: March 31, 2023

1.4K
Enzymatic Cascade Reactions for the Synthesis of Chiral Amino Alcohols from L-lysine
09:14

Enzymatic Cascade Reactions for the Synthesis of Chiral Amino Alcohols from L-lysine

Published on: February 16, 2018

12.6K
A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones
07:30

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

Published on: January 21, 2020

8.6K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Endocrinology

Background:

  • Diabetes mellitus is linked to elevated glucose levels and severe long-term complications like cardiovascular disease, retinopathy, and nephropathy.
  • The polyol pathway, involving the enzyme aldose reductase (AR), plays a key role in glucose metabolism and diabetic complications.
  • Aldose reductase inhibitors (ARIs) are investigated as a therapeutic strategy to mitigate sorbitol accumulation in the polyol pathway.

Purpose of the Study:

  • To review various chemical classes of aldose reductase inhibitors (ARIs).
  • To summarize advancements in ARI research for treating diabetic complications.
  • To explore potential applications of ARIs based on current data.

Main Methods:

  • Comprehensive literature search of scientific databases including PubMed, ScienceDirect, and SciFinder.
  • Analysis of structural classes of ARIs, including carboxylic acids, spirohydantoins, and phenolic derivatives.
  • Review of research findings on ARI efficacy and development.

Main Results:

  • Multiple structural classes of ARIs have been developed, including carboxylic acid derivatives (e.g., Epalrestat), spirohydantoins (e.g., Sorbinil), and phenolic derivatives.
  • Significant advancements have been made in ARI research, highlighting their potential in managing diabetic complications.
  • Data suggests various potential applications for ARIs in clinical settings.

Conclusions:

  • Aldose reductase inhibitors represent a promising therapeutic avenue for managing the long-term complications associated with diabetes mellitus.
  • Continued research and development of ARIs are crucial for optimizing their application in diabetic patient care.
  • Targeting the polyol pathway with novel ARI compounds may offer effective strategies to prevent or treat diabetic microvascular and macrovascular complications.